EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

2,8-Disubstituted-1,5-naphthyridines as Dual Inhibitors of Plasmodium falciparum Phosphatidylinositol-4-kinase and Hemozoin Formation with In Vivo Efficacy

Godwin Akpeko Dziwornu iD, Donald Seanego iD, Stephen Fienberg, Monica Clements, Jasmin Ferreira iD, Venkata S Sypu, Sauvik Samanta, Ashlyn D Bhana, Constance M Korkor, Larnelle F Garnie, Nicole Teixeira, Kathryn J Wicht iD und 23 weitere

Journal of Medicinal Chemistry · 11.07.2024 · 67 (13) · 11401-11420

DOI: 10.1021/acs.jmedchem.4c01154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 25.06.2024. Verfasst von Godwin Akpeko Dziwornu und 34 weiteren Autor:innen. Beteiligte Einrichtung: Drug Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa. Hauptthemen laut MEDLINE: Plasmodium falciparum, Naphthyridines, Antimalarials, 1-Phosphatidylinositol 4-Kinase. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Royal Society, Division of Intramural Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Structure-activity relationship studies of 2,8-disubstituted-1,5-naphthyridines, previously reported as potent inhibitors of Plasmodium falciparum (Pf) phosphatidylinositol-4-kinase β (PI4K), identified 1,5-naphthyridines with basic groups at 8-position, which retained Plasmodium PI4K inhibitory activity but switched primary mode of action to the host hemoglobin degradation pathway through inhibition of hemozoin formation. These compounds showed minimal off-target inhibitory activity against the human phosphoinositide kinases and MINK1 and MAP4K kinases, which were associated with the teratogenicity and testicular toxicity observed in rats for the PfPI4K inhibitor clinical candidate MMV390048. A representative compound from the series retained activity against field isolates and lab-raised drug-resistant strains of Pf. It was efficacious in the humanized NSG mouse malaria infection model at a single oral dose of 32 mg/kg. This compound was nonteratogenic in the zebrafish embryo model of teratogenicity and has a low predicted human dose, indicating that this series has the potential to deliver a preclinical candidate for malaria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasmodium falciparumNaphthyridinesAntimalarials1-Phosphatidylinositol 4-KinaseHemeproteinsZebrafishAnimalsHumansStructure-Activity RelationshipMiceRatsMalaria, FalciparumMaleProtein Kinase Inhibitors

Substanzen

NaphthyridineshemozoinAntimalarials1-Phosphatidylinositol 4-KinaseHemeproteinsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Drug Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa.
  • Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa.
  • Drug Discovery and Development Centre (H3D), Department of Chemistry and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch 7701, South Africa.
  • Drug Discovery and Development Centre (H3D), Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory 7925, South Africa.
  • Drug Discovery and Development Centre (H3D), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town 7925, South Africa.
  • Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123 Allschwil, Switzerland.

ORCID-Profile: Godwin Akpeko Dziwornu, Donald Seanego, Jasmin Ferreira, Kathryn J Wicht, Mathew Njoroge, Sergio Wittlin, Jacquin C Niles, Gregory S Basarab, Sandeep R Ghorpade, Kelly Chibale

Förderung

  • NIAID NIH HHS
  • Royal Society
  • Division of Intramural Research
  • African Academy of Sciences
  • Bill and Melinda Gates Foundation
  • Medicines for Malaria Venture
  • University of Cape Town
  • National Research Foundation

Zitieren

APA

Dziwornu, G. A., Seanego, D., Fienberg, S., Clements, M., Ferreira, J., Sypu, V. S., Samanta, S., Bhana, A. D., Korkor, C. M., Garnie, L. F., Teixeira, N., Wicht, K. J., Taylor, D., Olckers, R., Njoroge, M., Gibhard, L., Salomane, N., Wittlin, S., Mahato, R., …, & Chibale, K. (2024). 2,8-Disubstituted-1,5-naphthyridines as Dual Inhibitors of Plasmodium falciparum Phosphatidylinositol-4-kinase and Hemozoin Formation with In Vivo Efficacy. Journal of Medicinal Chemistry, 67(13), 11401-11420. https://doi.org/10.1021/acs.jmedchem.4c01154

Vancouver

Dziwornu GA, Seanego D, Fienberg S, Clements M, Ferreira J, Sypu VS, et al. 2,8-Disubstituted-1,5-naphthyridines as Dual Inhibitors of Plasmodium falciparum Phosphatidylinositol-4-kinase and Hemozoin Formation with In Vivo Efficacy. Journal of Medicinal Chemistry. 2024;67(13):11401-11420. doi:10.1021/acs.jmedchem.4c01154

BibTeX
@article{Dziwornu2024,
  author = {Dziwornu, Godwin Akpeko and Seanego, Donald and Fienberg, Stephen and Clements, Monica and Ferreira, Jasmin and Sypu, Venkata S and Samanta, Sauvik and Bhana, Ashlyn D and Korkor, Constance M and Garnie, Larnelle F and Teixeira, Nicole and Wicht, Kathryn J and Taylor, Dale and Olckers, Ronald and Njoroge, Mathew and Gibhard, Liezl and Salomane, Nicolaas and Wittlin, Sergio and Mahato, Rohit and Chakraborty, Arnish and Sevilleno, Nicole and Coyle, Rachael and Lee, Marcus C S and Godoy, Luiz C and Pasaje, Charisse Flerida and Niles, Jacquin C and Reader, Janette and van der Watt, Mariette and Birkholtz, Lyn-Marié and Bolscher, Judith M and de Bruijni, Marloes H C and Coulson, Lauren B and Basarab, Gregory S and Ghorpade, Sandeep R and Chibale, Kelly},
  title = {2,8-Disubstituted-1,5-naphthyridines as Dual Inhibitors of Plasmodium falciparum Phosphatidylinositol-4-kinase and Hemozoin Formation with In Vivo Efficacy},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  volume = {67},
  number = {13},
  pages = {11401--11420},
  doi = {10.1021/acs.jmedchem.4c01154}
}
Kostenlos starten →